Rising diabetes diagnosis in long COVID
- PMID: 35325625
- PMCID: PMC8937249
- DOI: 10.1016/S2213-8587(22)00078-X
Rising diabetes diagnosis in long COVID
Conflict of interest statement
We declare no competing interests. KMVN and LRS were partly supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (award number P30DK111024) and Rapid Acceleration of Diagnostics (award number P30KD11024–05S1). LRS was also partly supported by Georgia Clinical and Translational Science Awards UL1 (UL1TR002378) and KL2 (KL2TR002381). The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health.
Comment on
-
Risks and burdens of incident diabetes in long COVID: a cohort study.Lancet Diabetes Endocrinol. 2022 May;10(5):311-321. doi: 10.1016/S2213-8587(22)00044-4. Epub 2022 Mar 21. Lancet Diabetes Endocrinol. 2022. PMID: 35325624 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical